Epi Hlth Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EPI HLTH, and what generic alternatives to EPI HLTH drugs are available?
EPI HLTH has four approved drugs.
There are twelve US patents protecting EPI HLTH drugs.
There are sixty patent family members on EPI HLTH drugs in thirty countries and two supplementary protection certificates in two countries.
Summary for Epi Hlth
| International Patents: | 60 |
| US Patents: | 12 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Epi Hlth
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epi Hlth | SITAVIG | acyclovir | TABLET;BUCCAL | 203791-001 | Apr 12, 2013 | RX | Yes | Yes | 8,592,434 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Epi Hlth | RHOFADE | oxymetazoline hydrochloride | CREAM;TOPICAL | 208552-001 | Jan 18, 2017 | RX | Yes | Yes | 10,751,325 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Epi Hlth | RHOFADE | oxymetazoline hydrochloride | CREAM;TOPICAL | 208552-001 | Jan 18, 2017 | RX | Yes | Yes | 9,974,773 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Epi Hlth | RHOFADE | oxymetazoline hydrochloride | CREAM;TOPICAL | 208552-001 | Jan 18, 2017 | RX | Yes | Yes | 11,517,560 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Epi Hlth Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 2509586 | ⤷ Try a Trial |
| Denmark | 2509586 | ⤷ Try a Trial |
| European Patent Office | 3181121 | ⤷ Try a Trial |
| Cyprus | 1109723 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Epi Hlth Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
